Global Japanese Encephalitis (JE) Vaccine Market Insights, Forecast to 2025

Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. The vaccines are more than 90% effective. How long this protection lasts is not clear but its effectiveness appears to decrease over time. Doses are given either by injection into a muscle or just under the skin.
It is recommended as part of routine immunizations in countries where the disease is a problem. One or two doses are given depending on the version of the vaccine. Extra doses are not typically needed in areas where the disease is common. In those with HIV/AIDS or those who are pregnant an inactivated vaccine should be used. Immunization of travellers who plan to spend time outdoors in areas where the disease is common is recommended.
The global Japanese Encephalitis (JE) Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Japanese Encephalitis (JE) Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Japanese Encephalitis (JE) Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Japanese Encephalitis (JE) Vaccine in these regions.
This research report categorizes the global Japanese Encephalitis (JE) Vaccine market by top players/brands, region, type and end user. This report also studies the global Japanese Encephalitis (JE) Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GSK
Sanofi
Chengdu institute of biologica
Wuhan Institute of Biological
Lanzhou Institute of Biological
Beijing Taitan
Valneva
Bharat Biotech
Biological E. Limited
Liaoning Chengda

Market size by Product
Inactivated Vaccine
Live Attenuated Vaccine
Market size by End User
Public
Private

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Japanese Encephalitis (JE) Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Japanese Encephalitis (JE) Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Japanese Encephalitis (JE) Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Japanese Encephalitis (JE) Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Japanese Encephalitis (JE) Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Japanese Encephalitis (JE) Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Japanese Encephalitis (JE) Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Japanese Encephalitis (JE) Vaccine Market Size Growth Rate by Product
1.4.2 Inactivated Vaccine
1.4.3 Live Attenuated Vaccine
1.5 Market by End User
1.5.1 Global Japanese Encephalitis (JE) Vaccine Market Size Growth Rate by End User
1.5.2 Public
1.5.3 Private
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Japanese Encephalitis (JE) Vaccine Market Size
2.1.1 Global Japanese Encephalitis (JE) Vaccine Revenue 2014-2025
2.1.2 Global Japanese Encephalitis (JE) Vaccine Sales 2014-2025
2.2 Japanese Encephalitis (JE) Vaccine Growth Rate by Regions
2.2.1 Global Japanese Encephalitis (JE) Vaccine Sales by Regions
2.2.2 Global Japanese Encephalitis (JE) Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Japanese Encephalitis (JE) Vaccine Sales by Manufacturers
3.1.1 Japanese Encephalitis (JE) Vaccine Sales by Manufacturers
3.1.2 Japanese Encephalitis (JE) Vaccine Sales Market Share by Manufacturers
3.1.3 Global Japanese Encephalitis (JE) Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Japanese Encephalitis (JE) Vaccine Revenue by Manufacturers
3.2.1 Japanese Encephalitis (JE) Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Japanese Encephalitis (JE) Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Japanese Encephalitis (JE) Vaccine Price by Manufacturers
3.4 Japanese Encephalitis (JE) Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Japanese Encephalitis (JE) Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Japanese Encephalitis (JE) Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Japanese Encephalitis (JE) Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Japanese Encephalitis (JE) Vaccine Sales by Product
4.2 Global Japanese Encephalitis (JE) Vaccine Revenue by Product
4.3 Japanese Encephalitis (JE) Vaccine Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Japanese Encephalitis (JE) Vaccine Breakdown Data by End User

6 North America
6.1 North America Japanese Encephalitis (JE) Vaccine by Countries
6.1.1 North America Japanese Encephalitis (JE) Vaccine Sales by Countries
6.1.2 North America Japanese Encephalitis (JE) Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Japanese Encephalitis (JE) Vaccine by Product
6.3 North America Japanese Encephalitis (JE) Vaccine by End User

7 Europe
7.1 Europe Japanese Encephalitis (JE) Vaccine by Countries
7.1.1 Europe Japanese Encephalitis (JE) Vaccine Sales by Countries
7.1.2 Europe Japanese Encephalitis (JE) Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Japanese Encephalitis (JE) Vaccine by Product
7.3 Europe Japanese Encephalitis (JE) Vaccine by End User

8 Asia Pacific
8.1 Asia Pacific Japanese Encephalitis (JE) Vaccine by Countries
8.1.1 Asia Pacific Japanese Encephalitis (JE) Vaccine Sales by Countries
8.1.2 Asia Pacific Japanese Encephalitis (JE) Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Japanese Encephalitis (JE) Vaccine by Product
8.3 Asia Pacific Japanese Encephalitis (JE) Vaccine by End User

9 Central & South America
9.1 Central & South America Japanese Encephalitis (JE) Vaccine by Countries
9.1.1 Central & South America Japanese Encephalitis (JE) Vaccine Sales by Countries
9.1.2 Central & South America Japanese Encephalitis (JE) Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Japanese Encephalitis (JE) Vaccine by Product
9.3 Central & South America Japanese Encephalitis (JE) Vaccine by End User

10 Middle East and Africa
10.1 Middle East and Africa Japanese Encephalitis (JE) Vaccine by Countries
10.1.1 Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales by Countries
10.1.2 Middle East and Africa Japanese Encephalitis (JE) Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Japanese Encephalitis (JE) Vaccine by Product
10.3 Middle East and Africa Japanese Encephalitis (JE) Vaccine by End User

11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 Company Business Overview
11.1.3 GSK Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GSK Japanese Encephalitis (JE) Vaccine Products Offered
11.1.5 GSK Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Company Business Overview
11.2.3 Sanofi Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sanofi Japanese Encephalitis (JE) Vaccine Products Offered
11.2.5 Sanofi Recent Development
11.3 Chengdu institute of biologica
11.3.1 Chengdu institute of biologica Company Details
11.3.2 Company Business Overview
11.3.Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Products Offered
11.3.5 Chengdu institute of biologica Recent Development
11.4 Wuhan Institute of Biological
11.4.1 Wuhan Institute of Biological Company Details
11.4.2 Company Business Overview
11.4.3 Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Products Offered
11.4.5 Wuhan Institute of Biological Recent Development
11.5 Lanzhou Institute of Biological
11.5.1 Lanzhou Institute of Biological Company Details
11.5.2 Company Business Overview
11.5.3 Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Products Offered
11.5.5 Lanzhou Institute of Biological Recent Development
11.6 Beijing Taitan
11.6.1 Beijing Taitan Company Details
11.6.2 Company Business Overview
11.6.3 Beijing Taitan Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Beijing Taitan Japanese Encephalitis (JE) Vaccine Products Offered
11.6.5 Beijing Taitan Recent Development
11.7 Valneva
11.7.1 Valneva Company Details
11.7.2 Company Business Overview
11.7.3 Valneva Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Valneva Japanese Encephalitis (JE) Vaccine Products Offered
11.7.5 Valneva Recent Development
11.8 Bharat Biotech
11.8.1 Bharat Biotech Company Details
11.8.2 Company Business Overview
11.8.3 Bharat Biotech Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Bharat Biotech Japanese Encephalitis (JE) Vaccine Products Offered
11.8.5 Bharat Biotech Recent Development
11.9 Biological E. Limited
11.9.1 Biological E. Limited Company Details
11.9.2 Company Business Overview
11.9.3 Biological E. Limited Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Biological E. Limited Japanese Encephalitis (JE) Vaccine Products Offered
11.9.5 Biological E. Limited Recent Development
11.10 Liaoning Chengda
11.10.1 Liaoning Chengda Company Details
11.10.2 Company Business Overview
11.10.3 Liaoning Chengda Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Liaoning Chengda Japanese Encephalitis (JE) Vaccine Products Offered
11.10.5 Liaoning Chengda Recent Development

12 Future Forecast
12.1 Japanese Encephalitis (JE) Vaccine Market Forecast by Regions
12.1.1 Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Japanese Encephalitis (JE) Vaccine Revenue Forecast by Regions 2019-2025
12.2 Japanese Encephalitis (JE) Vaccine Market Forecast by Product
12.2.1 Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Japanese Encephalitis (JE) Vaccine Revenue Forecast by Product 2019-2025
12.3 Japanese Encephalitis (JE) Vaccine Market Forecast by End User
12.4 North America Japanese Encephalitis (JE) Vaccine Forecast
12.5 Europe Japanese Encephalitis (JE) Vaccine Forecast
12.6 Asia Pacific Japanese Encephalitis (JE) Vaccine Forecast
12.7 Central & South America Japanese Encephalitis (JE) Vaccine Forecast
12.8 Middle East and Africa Japanese Encephalitis (JE) Vaccine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Japanese Encephalitis (JE) Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Japanese Encephalitis (JE) Vaccine Product Picture
Table Japanese Encephalitis (JE) Vaccine Market Segments
Table Key Manufacturers Japanese Encephalitis (JE) Vaccine Covered
Table Global Japanese Encephalitis (JE) Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Product 2014-2025
Figure Inactivated Vaccine Product Picture
Table Major Manufacturers of Inactivated Vaccine
Figure Live Attenuated Vaccine Product Picture
Table Major Manufacturers of Live Attenuated Vaccine
Table Global Japanese Encephalitis (JE) Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Public
Figure Private
Figure Japanese Encephalitis (JE) Vaccine Report Years Considered
Figure Global Japanese Encephalitis (JE) Vaccine Market Size 2014-2025 (Million US$)
Figure Global Japanese Encephalitis (JE) Vaccine Sales 2014-2025 (K Doses)
Table Global Japanese Encephalitis (JE) Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Japanese Encephalitis (JE) Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Regions 2014-2019
Figure Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Regions
Table Global Japanese Encephalitis (JE) Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Regions
Table Global Japanese Encephalitis (JE) Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global Japanese Encephalitis (JE) Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Japanese Encephalitis (JE) Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Japanese Encephalitis (JE) Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Japanese Encephalitis (JE) Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Japanese Encephalitis (JE) Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Japanese Encephalitis (JE) Vaccine Price (2014-2019) (USD/Dose)
Table Japanese Encephalitis (JE) Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Japanese Encephalitis (JE) Vaccine Product Type
Table Date of International Manufacturers Enter into Japanese Encephalitis (JE) Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Japanese Encephalitis (JE) Vaccine Sales by Product (2014-2019) (K Doses)
Table Global Japanese Encephalitis (JE) Vaccine Sales Share by Product (2014-2019)
Figure Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Product (2014-2019)
Figure Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Product in 2018
Table Global Japanese Encephalitis (JE) Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Japanese Encephalitis (JE) Vaccine Revenue Share by Product (2014-2019)
Figure Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Product in 2018
Table Japanese Encephalitis (JE) Vaccine Price by Product 2014-2019 (USD/Dose)
Table Global Japanese Encephalitis (JE) Vaccine Sales by End User (2014-2019) (K Doses)
Table Global Japanese Encephalitis (JE) Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Japanese Encephalitis (JE) Vaccine Market Share by End User (2014-2019)
Figure Global Sales Japanese Encephalitis (JE) Vaccine Market Share by End User in 2018
Figure North America Japanese Encephalitis (JE) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure North America Japanese Encephalitis (JE) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Japanese Encephalitis (JE) Vaccine Sales by Countries (2014-2019) (K Doses)
Table North America Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries
Table North America Japanese Encephalitis (JE) Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries
Figure United States Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure United States Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Japanese Encephalitis (JE) Vaccine Sales by Product (2014-2019) (K Doses)
Table North America Japanese Encephalitis (JE) Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Japanese Encephalitis (JE) Vaccine Market Share by Product
Table North America Japanese Encephalitis (JE) Vaccine Sales by End User (2014-2019) (K Doses)
Table North America Japanese Encephalitis (JE) Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Japanese Encephalitis (JE) Vaccine Market Share by End User
Figure Europe Japanese Encephalitis (JE) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Japanese Encephalitis (JE) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Japanese Encephalitis (JE) Vaccine Sales by Countries (2014-2019) (K Doses)
Table Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries
Table Europe Japanese Encephalitis (JE) Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries
Figure Germany Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Germany Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure France Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure UK Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Japanese Encephalitis (JE) Vaccine Sales by Product (2014-2019) (K Doses)
Table Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Japanese Encephalitis (JE) Vaccine Market Share by Product
Table Europe Japanese Encephalitis (JE) Vaccine Sales by End User (2014-2019) (K Doses)
Table Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Japanese Encephalitis (JE) Vaccine Market Share by End User
Figure Asia Pacific Japanese Encephalitis (JE) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Japanese Encephalitis (JE) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Japanese Encephalitis (JE) Vaccine Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries
Table Asia Pacific Japanese Encephalitis (JE) Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries
Figure China Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure China Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Japanese Encephalitis (JE) Vaccine Sales by Product (2014-2019) (K Doses)
Table Asia Pacific Japanese Encephalitis (JE) Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Japanese Encephalitis (JE) Vaccine Market Share by Product
Table Asia Pacific Japanese Encephalitis (JE) Vaccine Sales by End User (2014-2019) (K Doses)
Table Asia Pacific Japanese Encephalitis (JE) Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Japanese Encephalitis (JE) Vaccine Market Share by End User
Figure Central & South America Japanese Encephalitis (JE) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Japanese Encephalitis (JE) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Japanese Encephalitis (JE) Vaccine Sales by Countries (2014-2019) (K Doses)
Table Central & South America Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries
Table Central & South America Japanese Encephalitis (JE) Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries
Figure Brazil Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Japanese Encephalitis (JE) Vaccine Sales by Product (2014-2019) (K Doses)
Table Central & South America Japanese Encephalitis (JE) Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Japanese Encephalitis (JE) Vaccine Market Share by Product
Table Central & South America Japanese Encephalitis (JE) Vaccine Sales by End User (2014-2019) (K Doses)
Table Central & South America Japanese Encephalitis (JE) Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Japanese Encephalitis (JE) Vaccine Market Share by End User
Figure Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Japanese Encephalitis (JE) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries
Table Middle East and Africa Japanese Encephalitis (JE) Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries
Figure GCC Countries Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Japanese Encephalitis (JE) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Japanese Encephalitis (JE) Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Japanese Encephalitis (JE) Vaccine Market Share by Product
Table Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Japanese Encephalitis (JE) Vaccine Market Share by End User
Table GSK Company Details
Table GSK Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table GSK Recent Development

Table Sanofi Company Details
Table Sanofi Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofi Recent Development

Table Chengdu institute of biologica Company Details
Table Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Chengdu institute of biologica Recent Development

Table Wuhan Institute of Biological Company Details
Table Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Wuhan Institute of Biological Recent Development

Table Lanzhou Institute of Biological Company Details
Table Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Lanzhou Institute of Biological Recent Development

Table Beijing Taitan Company Details
Table Beijing Taitan Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Beijing Taitan Recent Development

Table Valneva Company Details
Table Valneva Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Valneva Recent Development

Table Bharat Biotech Company Details
Table Bharat Biotech Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Bharat Biotech Recent Development

Table Biological E. Limited Company Details
Table Biological E. Limited Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Biological E. Limited Recent Development

Table Liaoning Chengda Company Details
Table Liaoning Chengda Japanese Encephalitis (JE) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Liaoning Chengda Recent Development

Table Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Global Japanese Encephalitis (JE) Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Japanese Encephalitis (JE) Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Japanese Encephalitis (JE) Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Product 2019-2025 (K Doses)
Table Global Japanese Encephalitis (JE) Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Japanese Encephalitis (JE) Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Japanese Encephalitis (JE) Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Japanese Encephalitis (JE) Vaccine Sales Forecast by End User 2019-2025 (K Doses)
Table Global Japanese Encephalitis (JE) Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Japanese Encephalitis (JE) Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America Japanese Encephalitis (JE) Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Japanese Encephalitis (JE) Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe Japanese Encephalitis (JE) Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Japanese Encephalitis (JE) Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific Japanese Encephalitis (JE) Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Japanese Encephalitis (JE) Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America Japanese Encephalitis (JE) Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa Japanese Encephalitis (JE) Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Japanese Encephalitis (JE) Vaccine Value Chain
Table Japanese Encephalitis (JE) Vaccine Customers List
Table Japanese Encephalitis (JE) Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type